Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-16

Clinical Trial Update: A Study to Determine the Safety and Efficacy of Bevacizumab Administered Via Injection Into the Shoulder Joint of Participants With Adhesive Capsulitis (Frozen Shoulder) [Phase 2]

View source ↗

Summary

A Phase 2 study to assess safety and efficacy of injecting bevacizumab into the shoulder joint for adhesive capsulitis (frozen shoulder), currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bevacizumab (Avastin) (bevacizumab)

Snippet

Sponsor: Macquarie University, Australia | Conditions: Adhesive Capsulitis | Phase 2 | Status: RECRUITING